Venture Life Share Discussion Threads

[cbootle] 17/7/2018 13:41

ARC's technical advantage was stronger 10 - 20 years ago, when doing anything truly real-time was hard. They created a network protocol and API which formed the basis of their products - real time databases, distribution, and the ability to take in many vendor market-data feeds, normalise them to a common format, and they re-publish them to all the vendors. Plus of course, displays on top of that (e.g. Excelerator, and their new product).

Real time data is now much easier, but ARC have built up a very wide moat in terms of their client base - as you've seen, their blue-chip clients are very slow to take up, very slow to let go. Essentially, they commit for life. ARC is fully funded by existing licence fees.

ARC is doing exactly the right thing by strengthening the moat through strong involvement in industry standards and groups. It means they are being seen as the "go-to" provider of alternative real-time financial market-data distribution, publishing and calculations, with a deep understanding of their clients' needs and requirements.

All IMO, GLA!

[apad] 17/7/2018 13:03

Bubble territory

I think my small techs (and not so small) will survive a bubble burst as they are genuine businesses with a decent advantage.
I am most pessimistic about the software only companies - LTG/PRSM/IDEA, so they are not for me.
ARC is on afterburners, despite not having many customers. It seems to have a technical advantage, but I don't understand what. Took a decent profit but far too soon and put it into FARN! At least I put the FARN residue into BVXP at the right time.

ZOO seems to be more of a business with a 'moat'. A commentator on CNN was saying that the other yoodle companies, e.g. HBO, Disney, are in full pursuit of Netflix, so it looks to be in a fertile world.
[My profit take is down 70% and my subsequent purchase of £434's worth is up 62%]
What a fopdoodle!

OPTI might work - it has a fantastic number of people following it (the board is nuts), which is worrying. What I don't understand is what protects it from competition with similar claims for non-medical chemicals. Still it is playing the 'brand' card very well - I might just buy a few to maintain my curiosity.

Off the radar companies like NTQ that are going to survive the downturn and have good technical products (my holding is up 25%) have attractions for the patient.

"err too long" I don't think so, red. Interest rate rises will be the key. But there is no wage inflation and .gov is running scared of a housing crash (which is most folks link to asset inflation). The 'Unreliable Boyfriend' might increase base rates from very small to very small and commentators will release a flood of words, but it won't be the start of a trend.
BREXIT will be in name only unless a general election is triggered and a strong brexiteer catches the imagination of voters.

So I'm fairly complacent as long as I don't get tempted into fairytale space.

Stairway is up 21% YTD. Easier last year than this year. FT All Share down 1%.

apad🤔

“We must respect the other fellow’s opinions, but only in the sense and to the extent that we respect his theory that his wife is beautiful and his children smart.”
Paraphrased from H L Mencken

[redartbmud] 17/7/2018 11:26

Looks like the buyer who was pushing up Ghh has exited the market for now and the share price has retreated to a more sensible valuation.

red

[redartbmud] 17/7/2018 11:21

APAD

Understand your comment on Bree. As my holding has doubled in value, since purchase, I am relatively bullet proof - famous last words.
The man at Bree is The chair, Peter Tom, but they do rum an efficient operation and the CEO is excellent.
It is a typical business where management knows the industry inside out and have a strategic plan for growth. In the longer term they will be much bigger. They are too canny to take unmeasured risks.
Tom is getting on in years and, like Bardon before, he will have his own exit plan in place.
Bound to benefit from infrastructure spend, as long as there is some money around to spend!!

The tech space is now in inflated bubble territory and there will be blood on the streets err too long. It is just a case of trying to second guess the impossible.

red

[apad] 17/7/2018 11:08

Ta red.
I dropped BREE from my watchlist as I don't favour cyclical shares.
Nearly kept it as an exception after your comments on the CEO.
I wonder if it will thrive when vanity projects such as HS2 are in full swing?

TSTL open day today (back to 300 from the large placings at 285) - I'm hoping that Paton will do one of his superb reports.
maynardpaton.com/2018/02/23/tristel-h1-results-boast-24-profit-jump-before-north-american-costs-as-epa-decision-now-set-for-16-april/#comment-12313

apad

[redartbmud] 17/7/2018 08:07

Comment on a gaming share that I had never heard of:

Racing for growth at Codemasters, says Liberum

Liberum has initiated coverage of racing game developer Codemasters (CDM), and it believes there are several opportunities for the business to grow revenues.

Analyst Andrew Bryant initiated coverage with a ‘buy’ recommendation and target price of 310p on the stock, which gained 0.9%, or 2p, to 217p.

He said the group has a ‘long track record as a leading UK AAA car racing computer game developer’.

‘There are several potential opportunities to build upon its three fully-owned IP franchises in addition to the licensed F1 games – with regular releases supported by a new revenue stream of digital services, growth in mobile, China and expanding eSports initiatives,’ he said.

‘This supports visible, annual sales growth of 12% over three years, while the continued transition to digital delivery supports structurally increasing margins.’


red

[redartbmud] 17/7/2018 08:05

APAD

Just for you, as you have expressed an interest in the past:

Outlook for Breedon boosted by takeover, says Peel Hunt

Breedon (BREE) has completed the acquisition of Lagan, boosting the prospects for the building materials supplier in an unexciting market, says Peel Hunt.

Analyst Clyde Lewis retained his ‘add’ recommendation and edged his target share price to 93p from 92p after updating forecasts to reflect the £455 million takeover of Lagan. He increased profit before tax forecasts for 2018 by £8 million and by £20 million in 2019, with earnings per share climbing 6% in 2019 and 9% in 2020.

‘While the overall UK construction outlook is not that exciting, Breedon’s end market exposures are more favourable – infrastructure and new housing especially,’ he said.

‘We continue to expect the group to improve its operational performance over time as it has consistently done over the last few years.’

The shares eased 0.4p or 0.5% to 81.6p on Monday.

red

[attrader] 16/7/2018 22:04

Thanks Apad

[attrader] 16/7/2018 22:03

Ta Hydrus.. I am liking Bunzl's story. They supply low value products (coffee cups, boxes, etc) but integrated with customers operations. They service clients in multiple sectors across the globe which makes it less cyclical..That allows them to acquire small family owned businesses, retain their entrepreneurial management, scale and grow consistently. Slow and steady growth business with good prospects..

[apad] 16/7/2018 22:02

hxxp://financials.morningstar.com/ratios/r.html?t=XLON:FEVR&region=GBR

Insiders - insider activity - Holding Summary

apad

[hydrus] 16/7/2018 21:26

Attrader - I don't have a lot to say it would be about five pages long because I think everything one needs to know about growth investing can be summarised over a few pages.

[attrader] 16/7/2018 21:19

APAD, whats the url for Morningstar Director Holdings?

[panic investor] 16/7/2018 20:48

Sounds like the government cabinet :-)

[apad] 16/7/2018 18:36

4 more DOTD vacancies (to 21) over the last fortnight.
apad

[janeann] 16/7/2018 18:21

Tristel announces that the Selling Directors have sold 2,462,000 Ordinary Shares in the Company (the "Placing Shares"), representing approximately 5.6 per cent. of the issued share capital of Tristel. The Placing Shares were placed at a price of 285 pence per share and were sold to institutional investors in a placing managed by finnCap Ltd acting as sole bookrunner ("finnCap" or "Bookrunner").



Following the above sale, Paul Swinney has no intention to sell any of his remaining equity interest in the Company for the foreseeable future.

[big7ime] 16/7/2018 16:46

Easier said than done Hydrus and well done on ZOO, I looked at it at 14p but didn't buy, doof!
There have been some stonking performers e.g. DTG up 100Times in 10yrs but annoyingly they are the type I'd never consider

[apad] 16/7/2018 16:39

DOTD trading statement on Wed.
Shares down 30% YTD.
Director sold 2million shares in March.
Dilution of 1.5million due to options in May.
Data regulations - unknown effects.

apad

[apad] 16/7/2018 15:19

Ta attrader. I've found my Morningstar source so will check it against sharesmagazine.

TSTL
Soler 1.7million out of 8.4 million
Barnes 197,085 out of 575,180.
Swinney (CEO) 502,915 looks like most of his holding.

Numbers will be a bit out of date because of recent activity - don't know if there has been recent options activity.

apad

[attrader] 16/7/2018 15:04

Check sharesmagazine site, they have director holding section and is pretty good

[apad] 16/7/2018 14:57

BTW my last record of TSTL director holdings was 22% of the company.

Used to have a good source for these data but can't find it anymore.
Any recommendations?

apad

[attrader] 16/7/2018 14:33

Hydrus - you should write a book:)

[apad] 16/7/2018 14:27

Date Director Type Volume / Price Trade value
11 Jun 2018 Paul Barnes Sell 15,000 @ 312.50p £46,875.00
01 Jun 2018 Francisco Soler Sell 50,000 @ 300.50p £150,250.00
01 Jun 2018 David Orr Buy 7,000 @ 306.05p £21,423.50
11 May 2018 Paul Swinney Sell 15,000 @ 315.00p £47,250.00
02 May 2018 Francisco Soler Buy 60,000 @ 300.00p £180,000.00

[attrader] 16/7/2018 14:25

TSTL - Managments misalignment with shareholders put me off investing ... It has gone up by 4x since then..

[apad] 16/7/2018 14:15

Perhaps because it's about 6% of the company?
Not a good sign though. "satisfy institutional investor demand" Yeah Right!
Soler has a history of selling companies and I'd rather expected Tristel to be taken over.
If I remember correctly the directors had an incentive to sell in the next couple of years.
There's an Open Day coming up shortly - I'd guess this will prompt some questions.
Don't like this sort of news.
apad😡